(Q35155955)

6 August 2017

1 reference

title

Tumors as elusive targets of T-cell-based active immunotherapy (English)

1 reference

6 August 2017

1 reference

3

Meenhard Herlyn

1 reference

6 August 2017

4

Barbara Seliger

1 reference

6 August 2017

5

Soldano Ferrone

1 reference

6 August 2017

1

Francesco M Marincola

1 reference

6 August 2017

2

Ena Wang

1 reference

6 August 2017

publication date

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

24

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

335-342

1 reference

Tumor antigens recognized by T cells

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

New paths in human cancer serology

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Vaccination for malignant melanoma: recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

T cell activation determined by T cell receptor number and tunable thresholds.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Supraoptimal peptide-major histocompatibility complex causes a decrease in bc1-2 levels and allows tumor necrosis factor alpha receptor II-mediated apoptosis of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Kinetics of TCR use in response to repeated epitope-specific immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Intensity of the vaccine-elicited immune response determines tumor clearance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Large clonal expansions of CD8+ T cells in acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Status of activation of circulating vaccine-elicited CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Functional heterogeneity of vaccine-induced CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Molecular and functional profiling of memory CD8 T cell differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Expansion of tumor-T cell pairs from fine needle aspirates of melanoma metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Tolerance, danger, and the extended family

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Is cancer dangerous to the immune system?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Immune surveillance against a solid tumor fails because of immunological ignorance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Cancer immunoprevention: tracking down persistent tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

A natural history of melanoma: serial gene expression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Short-term kinetics of tumor antigen expression in response to vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

High-fidelity mRNA amplification for gene profiling.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Exploring the new world of the genome with DNA microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

The dual role of IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Cancer as a complex adaptive system.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

1 reference

7 January 2021

The relevance of non-linear mathematics (chaos theory) to the treatment of cancer, the role of the immune response and the potential for vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Skewed maturation of memory HIV-specific CD8 T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2803%2900116-9

7 January 2021

10.1016/S1471-4906(03)00116-9

Identifiers

DOI

1 reference

6 August 2017

1 reference